1. 参考文献
2. [1] Younossi Z M, Koenig A B, Abdelatif D, et al. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.[J]. Hepatology (Baltimore, Md.), 2016,64(1):73-84.
3. [2] Younossi Z M, Ratziu V, Loomba R, et al. Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial.[Z]. 2019: 394, 2184-2196.
4. [J];Buzzetti;Metabolism,2016
5. [J];Goldberg;Gastroenterology,2017